Human MDR gene transfer in patients with advanced cancer.
C
C
Hesdorffer
K
K
Antman
A
A
Bank
M
M
Fetell
G
G
Mears
M
M
Begg
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000096:biosynthesis / Q000235:genetics*; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001855:Bone Marrow Diseases / Q000139:chemically induced / Q000628:therapy*; D016026:Bone Marrow Transplantation; D002478:Cells, Cultured; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D004351:Drug Resistance / Q000235:genetics; D005260:Female; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000009:adverse effects; D005822:Genetic Vectors; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D010865:Pilot Projects; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D012074:Remission Induction; D012190:Retroviridae / Q000235:genetics; D012449:Safety
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D011993:Recombinant Fusion Proteins